Back to search
Metastatic Uveal Melanoma in the Liver
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Metastatic Uveal Melanoma in the Liver trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Metastatic Uveal Melanoma in the Liver trials you may qualify forThe purpose of this study is to determine the effects (good and bad) that Tebentafusp in combination with Yttrium-90 (Y-90) radioembolization has on patients wi…
This study is a multicenter, open label phase I/ II trial to assess the safety and clinical efficacy of tebentafusp-tebn in combination with liver-directed ther…
A recent clinical trial found that after 36 months, patients taking tebentafusp had a median survival of 21.6 months, compared to 16.9 months for those in the c…
This phase II trial studies the effect of transarterial chemoembolization in treating patients with uveal melanoma that has spread to the liver (liver metastase…
This study is an open-label, phase 1/1b study of the pressure-enabled hepatic artery infusion of SD-101, a TLR 9 agonist, alone or in combination with intraveno…